Investment

US Stocks

Invest in the world’s largest market with US Stocks

Crypto

Unleash the unlimited potential of Crypto

Mutual Funds

Worry-free investments with Mutual Funds

Gold

The simplest way to invest in Gold

Options

Maximize market opportunities with Options Trading

Explore

Choose from 1000+ available assets

Features

Pro Tools for Pro Traders

Uncover the powerful trading features

Pro Features

Pluang Web Trading

Leverage

Built for Investors

Experience investing with simplified features

Pockets

Recurring Buy

USD Yield

Pluang Cuan

Fees

Safety

Academy

Latest for You

Get up-to-date financial news and investing tips & information

Blog

Find various tips & information to become a knowledgeable investor

News and Analysis

Read the latest information about finance and investment

Learn

Become a smarter investor by learning the basics of investing

Glossary

Learn investment terms to understand investing better

More

Promo & Referral

Discover exclusive opportunities to level up your investments

Investment Clubs (Coming Soon)

Join hands with like-minded investors to grow wealth together

Press (Coming Soon)

Stay updated with our latest news and media coverage

Support

About Us

Contact

Ask

Career

Tax Reporting Guide

Pluang+

|

Eli Lilly And Co (LLY) Stock Price Today

Overview

Financial

Technicals

Analysis

Corporate Action

About

About Eli Lilly And Co

Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer

Technical Indicators

|

|

|

Overall Summary

Bearish (6)

Neutral (8)

Bullish (13)

Performance

LLY ROI

+25.49%

% from 52W High

-21.88%

$749.92

52W Low: $570.21

20 Dec 2023

52W High: $960.02

30 Aug 2024

News

The Motley Fool

5d

Prediction: 3 Stocks That'll Be Worth More Than Tesla 10 Years From Now

The Motley Fool

5d

2 Reasons to Buy Amgen Stock, and 1 Reason to Be Cautious

The Motley Fool

6d

Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On.

The Motley Fool

7d

Should You Forget Eli Lilly and Buy This Magnificent Biotech Stock Instead?

The Motley Fool

8d

Is AstraZeneca a Buy as It Eyes the Weight Loss Market?

US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions

register_card

Let’s trade or invest in this asset by signing up or logging in!

You can also download our app!

item

item

item